Scott L. Pomeroy - Publications

Affiliations: 
Neurology Harvard Medical School, Boston Children's Hospital 
Area:
embryonal brain tumors, cell proliferation and differentiation

143 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Archer TC, Ehrenberger T, Mundt F, Gold MP, Krug K, Mah CK, Mahoney EL, Daniel CJ, LeNail A, Ramamoorthy D, Mertins P, Mani DR, Zhang H, Gillette MA, Clauser K, ... ... Pomeroy SL, et al. Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 34: 396-410.e8. PMID 30205044 DOI: 10.1016/j.ccell.2018.08.004  0.96
2018 Clark AR, Calligaris D, Regan MS, Pomeranz Krummel D, Agar JN, Kallay L, MacDonald T, Schniederjan M, Santagata S, Pomeroy SL, Agar NYR, Sengupta S. Rapid discrimination of pediatric brain tumors by mass spectrometry imaging. Journal of Neuro-Oncology. PMID 30128689 DOI: 10.1007/s11060-018-2978-2  0.96
2018 Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugières L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, ... ... Pomeroy SL, et al. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. The Lancet. Oncology. PMID 29753700 DOI: 10.1016/S1470-2045(18)30242-0  0.96
2018 Archer TC, Sengupta S, Pomeroy SL. Brain cancer genomics and epigenomics. Handbook of Clinical Neurology. 148: 785-797. PMID 29478614 DOI: 10.1016/B978-0-444-64076-5.00050-8  0.96
2017 Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gröbner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz HJ, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, ... ... Pomeroy SL, et al. The whole-genome landscape of medulloblastoma subtypes. Nature. 547: 311-317. PMID 28726821 DOI: 10.1038/nature22973  1
2017 Archer TC, Mahoney EL, Pomeroy SL. Medulloblastoma: Molecular Classification-Based Personal Therapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28386677 DOI: 10.1007/s13311-017-0526-y  0.96
2017 Boulay G, Awad ME, Riggi N, Archer TC, Iyer S, Boonseng WE, Rossetti NE, Naigles B, Rengarajan S, Volorio A, Kim JC, Mesirov JP, Tamayo P, Pomeroy SL, Aryee MJ, et al. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma. Cancer Discovery. PMID 28213356 DOI: 10.1158/2159-8290.CD-16-0844  0.96
2016 Wang X, Lee RS, Alver BH, Haswell JR, Wang S, Mieczkowski J, Drier Y, Gillespie SM, Archer TC, Wu JN, Tzvetkov EP, Troisi EC, Pomeroy SL, Biegel JA, Tolstorukov MY, et al. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation. Nature Genetics. PMID 27941797 DOI: 10.1038/ng.3746  0.96
2016 Jonas O, Calligaris D, Methuku KR, Poe MM, Francois JP, Tranghese F, Changelian A, Sieghart W, Ernst M, Krummel DA, Cook JM, Pomeroy SL, Cima M, Agar NY, Langer R, et al. First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development. Journal of Biomedical Nanotechnology. 12: 1297-302. PMID 27319222 DOI: 10.1166/jbn.2016.2262  1
2016 Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, ... ... Pomeroy SL, et al. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathologica. PMID 27040285 DOI: 10.1007/s00401-016-1569-6  1
2016 Hanaford AR, Archer TC, Price A, Kahlert UD, Maciaczyk J, Nikkhah G, Kim JW, Ehrenberger T, Clemons PA, Dančík V, Seashore-Ludlow B, Viswanathan V, Stewart ML, Rees M, Shamji AF, ... ... Pomeroy SL, et al. DiSCoVERing innovative therapies for rare tumors: combining genetically accurate disease models with in silico analysis to identify novel therapeutic targets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27012813 DOI: 10.1158/1078-0432.CCR-15-3011  1
2015 Ullrich NJ, Pomeroy SL, Kapur K, Manley PE, Goumnerova LC, Loddenkemper T. Incidence, risk factors, and longitudinal outcome of seizures in long-term survivors of pediatric brain tumors. Epilepsia. PMID 26332282 DOI: 10.1111/epi.13112  1
2015 Archer TC, Pomeroy SL. Defining the molecular landscape of ependymomas. Cancer Cell. 27: 613-5. PMID 25965568 DOI: 10.1016/j.ccell.2015.04.015  1
2014 Zhukova N, Ramaswamy V, Remke M, Martin DC, Castelo-Branco P, Zhang CH, Fraser M, Tse K, Poon R, Shih DJ, Baskin B, Ray PN, Bouffet E, Dirks P, von Bueren AO, ... ... Pomeroy SL, et al. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma. Acta Neuropathologica Communications. 2: 174. PMID 25539912 DOI: 10.1186/s40478-014-0174-y  1
2014 Sengupta S, Weeraratne SD, Cho YJ, Pomeroy SL. Could α5-GABA-A receptor activation be used as a target for managing medulloblastomas? Cns Oncology. 3: 245-7. PMID 25286034 DOI: 10.2217/cns.14.27  0.96
2014 He X, Zhang L, Chen Y, Remke M, Shih D, Lu F, Wang H, Deng Y, Yu Y, Xia Y, Wu X, Ramaswamy V, Hu T, Wang F, Zhou W, ... ... Pomeroy SL, et al. The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma. Nature Medicine. 20: 1035-42. PMID 25150496 DOI: 10.1038/nm.3666  1
2014 Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M, Kim SK, Ra YS, Nakamura H, Fangusaro J, Hwang E, Kiehna E, Toledano H, Wang Y, Shi Q, ... ... Pomeroy SL, et al. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathologica. 128: 291-303. PMID 24839957 DOI: 10.1007/s00401-014-1291-1  1
2014 Kool M, Jones DT, Jäger N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, ... ... Pomeroy SL, et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell. 25: 393-405. PMID 24651015 DOI: 10.1016/j.ccr.2014.02.004  1
2014 Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stütz AM, Wang X, Gallo M, Garzia L, Zayne K, Zhang X, Ramaswamy V, Jäger N, Jones DT, Sill M, ... ... Pomeroy SL, et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature. 506: 445-50. PMID 24553142 DOI: 10.1038/nature13108  0.92
2014 Shih DJ, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM, Garzia L, Peacock J, Mack SC, Wu X, Rolider A, ... ... Pomeroy SL, et al. Cytogenetic prognostication within medulloblastoma subgroups. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 886-96. PMID 24493713 DOI: 10.1200/JCO.2013.50.9539  1
2014 Archer TC, Pomeroy SL. A developmental program drives aggressive embryonal brain tumors. Nature Genetics. 46: 2-3. PMID 24370739 DOI: 10.1038/ng.2857  1
2014 Gottardo NG, Hansford JR, McGlade JP, Alvaro F, Ashley DM, Bailey S, Baker DL, Bourdeaut F, Cho YJ, Clay M, Clifford SC, Cohn RJ, Cole CH, Dallas PB, Downie P, ... ... Pomeroy SL, et al. Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathologica. 127: 189-201. PMID 24264598 DOI: 10.1007/s00401-013-1213-7  1
2014 Akhavanfard S, Vargas SO, Han M, Nitta M, Chang CB, Le LP, Fazlollahi L, Nguyen Q, Ma Y, Cosper A, Dias-Santagata D, Han JY, Bergethon K, Borger DR, Ellisen LW, ... Pomeroy SL, et al. Inactivation of the tumor suppressor WTX in a subset of pediatric tumors. Genes, Chromosomes & Cancer. 53: 67-77. PMID 24249259 DOI: 10.1002/gcc.22118  1
2014 Sengupta S, Weeraratne SD, Sun H, Phallen J, Rallapalli SK, Teider N, Kosaras B, Amani V, Pierre-Francois J, Tang Y, Nguyen B, Yu F, Schubert S, Balansay B, Mathios D, ... ... Pomeroy SL, et al. α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth. Acta Neuropathologica. 127: 593-603. PMID 24196163 DOI: 10.1007/s00401-013-1205-7  1
2014 Mora-Blanco EL, Mishina Y, Tillman EJ, Cho YJ, Thom CS, Pomeroy SL, Shao W, Roberts CW. Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5. Oncogene. 33: 933-8. PMID 23435428 DOI: 10.1038/onc.2013.37  1
2013 Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, ... ... Pomeroy SL, et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathologica. 126: 917-29. PMID 24174164 DOI: 10.1007/s00401-013-1198-2  1
2013 Ramaswamy V, Remke M, Bouffet E, Faria CC, Perreault S, Cho YJ, Shih DJ, Luu B, Dubuc AM, Northcott PA, Schüller U, Gururangan S, McLendon R, Bigner D, Fouladi M, ... ... Pomeroy SL, et al. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. The Lancet. Oncology. 14: 1200-7. PMID 24140199 DOI: 10.1016/S1470-2045(13)70449-2  1
2013 Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC, Castelo-Branco P, Baskin B, Ray PN, Bouffet E, von Bueren AO, Jones DT, Northcott PA, Kool M, Sturm D, ... ... Pomeroy SL, et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2927-35. PMID 23835706 DOI: 10.1200/JCO.2012.48.5052  1
2013 Jones DT, Hutter B, Jäger N, Korshunov A, Kool M, Warnatz HJ, Zichner T, Lambert SR, Ryzhova M, Quang DA, Fontebasso AM, Stütz AM, Hutter S, Zuckermann M, Sturm D, ... ... Pomeroy SL, et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nature Genetics. 45: 927-32. PMID 23817572 DOI: 10.1038/ng.2682  1
2013 Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, McKenna A, Lawrence MS, Bergthold G, Brastianos PK, Tabak B, Ducar MD, Van Hummelen P, MacConaill LE, Pouissant-Young T, ... ... Pomeroy SL, et al. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proceedings of the National Academy of Sciences of the United States of America. 110: 8188-93. PMID 23633565 DOI: 10.1073/pnas.1300252110  1
2013 Leviton A, Loddenkemper T, Pomeroy SL. Clinical practice guidelines and practice parameters for the child neurologist. Journal of Child Neurology. 28: 917-25. PMID 23576411 DOI: 10.1177/0883073813483362  1
2013 Chew S, Balasubramanian R, Chan WM, Kang PB, Andrews C, Webb BD, MacKinnon SE, Oystreck DT, Rankin J, Crawford TO, Geraghty M, Pomeroy SL, Crowley WF, Jabs EW, Hunter DG, et al. A novel syndrome caused by the E410K amino acid substitution in the neuronal β-tubulin isotype 3. Brain : a Journal of Neurology. 136: 522-35. PMID 23378218 DOI: 10.1093/brain/aws345  1
2012 Archer TC, Pomeroy SL. Medulloblastoma biology in the post-genomic era. Future Oncology (London, England). 8: 1597-604. PMID 23231521 DOI: 10.2217/fon.12.151  1
2012 Northcott PA, Jones DT, Kool M, Robinson GW, Gilbertson RJ, Cho YJ, Pomeroy SL, Korshunov A, Lichter P, Taylor MD, Pfister SM. Medulloblastomics: the end of the beginning. Nature Reviews. Cancer. 12: 818-34. PMID 23175120 DOI: 10.1038/nrc3410  1
2012 Tasker RC, Pomeroy SL. Sport-related concussion: time to take notice. Current Opinion in Pediatrics. 24: 687-8. PMID 23111682 DOI: 10.1097/MOP.0b013e32835a29ae  1
2012 Jones DT, Jäger N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stütz AM, Rausch T, Warnatz HJ, Ryzhova M, Bender S, Sturm D, ... ... Pomeroy SL, et al. Dissecting the genomic complexity underlying medulloblastoma. Nature. 488: 100-5. PMID 22832583 DOI: 10.1038/nature11284  1
2012 Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE, Beroukhim R, Ellison DW, Marshall CR, Lionel AC, Mack S, ... ... Pomeroy SL, et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature. 488: 49-56. PMID 22832581 DOI: 10.1038/nature11327  0.92
2012 Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J, Carneiro MO, Carter SL, Cibulskis K, Erlich RL, Greulich H, Lawrence MS, Lennon NJ, McKenna A, Meldrim J, ... ... Pomeroy SL, et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature. 488: 106-10. PMID 22820256 DOI: 10.1038/nature11329  1
2012 Picard D, Miller S, Hawkins CE, Bouffet E, Rogers HA, Chan TS, Kim SK, Ra YS, Fangusaro J, Korshunov A, Toledano H, Nakamura H, Hayden JT, Chan J, Lafay-Cousin L, ... ... Pomeroy SL, et al. Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. The Lancet. Oncology. 13: 838-48. PMID 22691720 DOI: 10.1016/S1470-2045(12)70257-7  1
2012 McKenna ES, Tamayo P, Cho YJ, Tillman EJ, Mora-Blanco EL, Sansam CG, Koellhoffer EC, Pomeroy SL, Roberts CW. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors. Cell Cycle (Georgetown, Tex.). 11: 1956-65. PMID 22544318 DOI: 10.4161/cc.20280  1
2012 Manley PE, McKendrick K, McGillicudy M, Chi SN, Kieran MW, Cohen LE, Kothare S, Michael Scott R, Goumnerova LC, Sun P, London W, Marcus KJ, Pomeroy SL, Ullrich NJ. Sleep dysfunction in long term survivors of craniopharyngioma. Journal of Neuro-Oncology. 108: 543-9. PMID 22528788 DOI: 10.1007/s11060-012-0859-7  1
2012 Archer TC, Weeraratne SD, Pomeroy SL. Hedgehog-GLI pathway in medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2154-6. PMID 22508821 DOI: 10.1200/JCO.2011.41.1181  1
2012 Weeraratne SD, Amani V, Teider N, Pierre-Francois J, Winter D, Kye MJ, Sengupta S, Archer T, Remke M, Bai AH, Warren P, Pfister SM, Steen JA, Pomeroy SL, Cho YJ. Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathologica. 123: 539-52. PMID 22402744 DOI: 10.1007/s00401-012-0969-5  1
2012 Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, Cho YJ, Koster J, Schouten-van Meeteren A, van Vuurden D, Clifford SC, Pietsch T, von Bueren AO, Rutkowski S, McCabe M, ... ... Pomeroy SL, et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathologica. 123: 473-84. PMID 22358457 DOI: 10.1007/s00401-012-0958-8  1
2012 Bai AH, Milde T, Remke M, Rolli CG, Hielscher T, Cho YJ, Kool M, Northcott PA, Jugold M, Bazhin AV, Eichmüller SB, Kulozik AE, Pscherer A, Benner A, Taylor MD, ... Pomeroy SL, et al. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathologica. 123: 529-38. PMID 22134538 DOI: 10.1007/s00401-011-0924-x  1
2012 Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathologica. 123: 465-72. PMID 22134537 DOI: 10.1007/s00401-011-0922-z  1
2012 Northcott PA, Shih DJ, Remke M, Cho YJ, Kool M, Hawkins C, Eberhart CG, Dubuc A, Guettouche T, Cardentey Y, Bouffet E, Pomeroy SL, Marra M, Malkin D, Rutka JT, et al. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathologica. 123: 615-26. PMID 22057785 DOI: 10.1007/s00401-011-0899-7  1
2011 Ullrich NJ, Pomeroy SL. Neuro-oncology training for the child neurology resident. Seminars in Pediatric Neurology. 18: 120-2. PMID 22036496 DOI: 10.1016/j.spen.2011.06.010  1
2011 Spence SJ, Tasker RC, Pomeroy SL. Recent advances in autism spectrum disorders. Current Opinion in Pediatrics. 23: 607-8. PMID 21970831 DOI: 10.1097/MOP.0b013e32834cbb31  1
2011 Archer TC, Pomeroy SL. Posterior fossa ependymomas: a tale of two subtypes. Cancer Cell. 20: 133-4. PMID 21840477 DOI: 10.1016/j.ccr.2011.08.003  1
2011 Winkfield KM, Tsai HK, Yao X, Larson E, Neuberg D, Pomeroy SL, Ullrich NJ, Cohen LE, Kieran MW, Scott RM, Goumnerova LC, Marcus KJ. Long-term clinical outcomes following treatment of childhood craniopharyngioma. Pediatric Blood & Cancer. 56: 1120-6. PMID 21488157 DOI: 10.1002/pbc.22884  1
2011 Pomeroy SL, Cho YJ. Molecular fingerprints of medulloblastoma and their application to clinical practice. Future Oncology (London, England). 7: 327-9. PMID 21417897 DOI: 10.2217/fon.11.15  1
2011 Tamayo P, Cho YJ, Tsherniak A, Greulich H, Ambrogio L, Schouten-van Meeteren N, Zhou T, Buxton A, Kool M, Meyerson M, Pomeroy SL, Mesirov JP. Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1415-23. PMID 21357789 DOI: 10.1200/JCO.2010.28.1675  1
2011 Wu H, Pomeroy SL, Ferreira M, Teider N, Mariani J, Nakayama KI, Hatakeyama S, Tron VA, Saltibus LF, Spyracopoulos L, Leng RP. UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53. Nature Medicine. 17: 347-55. PMID 21317885 DOI: 10.1038/nm.2283  1
2011 Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nature Communications. 2: 180. PMID 21285958 DOI: 10.1038/ncomms1180  1
2011 Weeraratne SD, Amani V, Neiss A, Teider N, Scott DK, Pomeroy SL, Cho YJ. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro-Oncology. 13: 165-75. PMID 21177782 DOI: 10.1093/neuonc/noq179  1
2011 Cho YJ, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG, Lau CC, Olson JM, Gilbertson RJ, Gajjar A, Delattre O, ... ... Pomeroy SL, et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1424-30. PMID 21098324 DOI: 10.1200/JCO.2010.28.5148  0.92
2010 Gorman MP, Tasker RC, Pomeroy SL. Growing spectrum and relevance of pediatric neuro-immunology. Current Opinion in Pediatrics. 22: 717. PMID 21610330 DOI: 10.1097/MOP.0b013e3283402d83  1
2010 Jagani Z, Mora-Blanco EL, Sansam CG, McKenna ES, Wilson B, Chen D, Klekota J, Tamayo P, Nguyen PT, Tolstorukov M, Park PJ, Cho YJ, Hsiao K, Buonamici S, Pomeroy SL, et al. Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway. Nature Medicine. 16: 1429-33. PMID 21076395 DOI: 10.1038/nm.2251  1
2010 Wilson BG, Wang X, Shen X, McKenna ES, Lemieux ME, Cho YJ, Koellhoffer EC, Pomeroy SL, Orkin SH, Roberts CW. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell. 18: 316-28. PMID 20951942 DOI: 10.1016/j.ccr.2010.09.006  1
2010 Teider N, Scott DK, Neiss A, Weeraratne SD, Amani VM, Wang Y, Marquez VE, Cho YJ, Pomeroy SL. Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma. Neuro-Oncology. 12: 1244-56. PMID 20847082 DOI: 10.1093/neuonc/noq091  1
2010 Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, ... ... Pomeroy SL, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 463: 899-905. PMID 20164920 DOI: 10.1038/nature08822  1
2010 Tischfield MA, Baris HN, Wu C, Rudolph G, Van Maldergem L, He W, Chan WM, Andrews C, Demer JL, Robertson RL, Mackey DA, Ruddle JB, Bird TD, Gottlob I, Pieh C, ... ... Pomeroy SL, et al. Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell. 140: 74-87. PMID 20074521 DOI: 10.1016/j.cell.2009.12.011  1
2010 Robin NH, Pomeroy SL, Tasker RC, Gorman MP, Notarangelo LD, Cabana M. Current Opinion in Pediatrics: Editorial introductions Current Opinion in Pediatrics. 22: vii-ix. DOI: 10.1097/MOP.0b013e3283412601  1
2010 Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C, Peter Collins V, Van Meter T, Picard D, Zhou L, Boutros P, Modena P, Liang ML, Scherer SW, Bouffet E, ... ... Pomeroy S, et al. Frequent Amplification of a chr19q13.41 MicroRNA Polycistron in Aggressive Primitive Neuroectodermal Brain Tumors (DOI:10.1016/j.ccr.2009.10.025) Cancer Cell. 17: 413. DOI: 10.1016/j.ccr.2010.03.016  1
2010 Cho YJ, Pomeroy SL. Targeted therapy in medulloblastoma in molecularly targeted therapy for childhood cancer Molecularly Targeted Therapy For Childhood Cancer. 267-290. DOI: 10.1007/978-0-387-69062-9_13  1
2009 Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C, Collins VP, Van Meter T, Picard D, Zhou L, Boutros PC, Modena P, Liang ML, Scherer SW, Bouffet E, ... ... Pomeroy SL, et al. Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell. 16: 533-46. PMID 19962671 DOI: 10.1016/j.ccr.2009.10.025  1
2009 Pomeroy SL. Pathologic intracellular signaling in childhood pilocytic astrocytomas. Neurology. 73: 1522-3. PMID 19812379 DOI: 10.1212/WNL.0b013e3181c1850e  1
2009 Lipton J, Megerian JT, Kothare SV, Cho YJ, Shanahan T, Chart H, Ferber R, Adler-Golden L, Cohen LE, Czeisler CA, Pomeroy SL. Melatonin deficiency and disrupted circadian rhythms in pediatric survivors of craniopharyngioma. Neurology. 73: 323-5. PMID 19636054 DOI: 10.1212/WNL.0b013e3181af78a5  1
2008 Kothare SV, Pomeroy SL. Pediatric sleep medicine in 2008: state-of-the-art. Current Opinion in Pediatrics. 20: 639-40. PMID 19023916 DOI: 10.1097/MOP.0b013e328317ee99  1
2008 Waber DP, Pomeroy SL. Introduction: survivors of childhood cancer: the new face of developmental disabilities. Developmental Disabilities Research Reviews. 14: 183-4. PMID 18924153 DOI: 10.1002/ddrr.28  1
2008 McKenna ES, Sansam CG, Cho YJ, Greulich H, Evans JA, Thom CS, Moreau LA, Biegel JA, Pomeroy SL, Roberts CW. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Molecular and Cellular Biology. 28: 6223-33. PMID 18710953 DOI: 10.1128/MCB.00658-08  1
2008 Yang DP, Zhang DP, Mak KS, Bonder DE, Pomeroy SL, Kim HA. Schwann cell proliferation during Wallerian degeneration is not necessary for regeneration and remyelination of the peripheral nerves: axon-dependent removal of newly generated Schwann cells by apoptosis. Molecular and Cellular Neurosciences. 38: 80-8. PMID 18374600 DOI: 10.1016/j.mcn.2008.01.017  1
2008 Mong S, Pomeroy SL, Cecchin F, Juraszek A, Alexander ME. Cardiac risk after craniopharyngioma therapy. Pediatric Neurology. 38: 256-60. PMID 18358404 DOI: 10.1016/j.pediatrneurol.2007.11.007  1
2008 Schlisio S, Kenchappa RS, Vredeveld LC, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, Pomeroy SL, Maris JM, Look AT, Meyerson M, Peeper DS, et al. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes & Development. 22: 884-93. PMID 18334619 DOI: 10.1101/gad.1648608  1
2008 Ullrich NJ, Pomeroy SL. Neurologic complications of pediatric systemic cancer Cancer Neurology in Clinical Practice: Neurologic Complications of Cancer and Its Treatment: Second Edition. 607-619. DOI: 10.1007/978-1-59745-412-4_32  1
2007 Lo KC, Ma C, Bundy BN, Pomeroy SL, Eberhart CG, Cowell JK. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7022-8. PMID 18056178 DOI: 10.1158/1078-0432.CCR-07-1420  1
2007 Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, Chi SN, Goumnerova L, Proctor M, Tarbell NJ, Marcus KJ, Pomeroy SL. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 68: 932-8. PMID 17372129 DOI: 10.1212/01.wnl.0000257095.33125.48  1
2007 Lo KC, Rossi MR, Burkhardt T, Pomeroy SL, Cowell JK. Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas. Genes, Chromosomes & Cancer. 46: 53-66. PMID 17044047 DOI: 10.1002/gcc.20388  1
2006 Ferreira M, Pomeroy SL. Medulloblastoma Subtypes Defined by Gene Expression Analysis 864. Neurosurgery. 59: 475. PMID 28180699 DOI: 10.1227/01.NEU.0000309914.51294.14  0.96
2006 Ullrich NJ, Pomeroy SL. Molecular genetics of pediatric central nervous system tumors. Current Oncology Reports. 8: 423-9. PMID 17040620 DOI: 10.1007/s11912-006-0070-0  1
2006 De Bortoli M, Castellino RC, Lu XY, Deyo J, Sturla LM, Adesina AM, Perlaky L, Pomeroy SL, Lau CC, Man TK, Rao PH, Kim JY. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8. Bmc Cancer. 6: 223. PMID 16968546 DOI: 10.1186/1471-2407-6-223  1
2006 Ullrich NJ, Marcus K, Pomeroy SL, Turner CD, Zimmerman M, Lehmann LE, Scott RM, Goumnerova L, Gillan E, Kieran MW, Chi SN. Transverse myelitis after therapy for primitive neuroectodermal tumors. Pediatric Neurology. 35: 122-5. PMID 16876009 DOI: 10.1016/j.pediatrneurol.2006.01.013  1
2006 Waber DP, Pomeroy SL, Chiverton AM, Kieran MW, Scott RM, Goumnerova LC, Rivkin MJ. Everyday cognitive function after craniopharyngioma in childhood. Pediatric Neurology. 34: 13-9. PMID 16376272 DOI: 10.1016/j.pediatrneurol.2005.06.002  1
2006 Ullrich NJ, Pomeroy SL. Microarray analysis and proteomic approaches to drug development Handbook of Brain Tumor Chemotherapy. 74-88. DOI: 10.1016/B978-012088410-0/50043-3  1
2005 Isakoff MS, Sansam CG, Tamayo P, Subramanian A, Evans JA, Fillmore CM, Wang X, Biegel JA, Pomeroy SL, Mesirov JP, Roberts CW. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proceedings of the National Academy of Sciences of the United States of America. 102: 17745-50. PMID 16301525 DOI: 10.1073/pnas.0509014102  1
2005 Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America. 102: 15545-50. PMID 16199517 DOI: 10.1073/pnas.0506580102  1
2005 Bonkowsky JL, Sarco D, Pomeroy SL. Ataxia and shaking in a 2-year-old girl: acute marijuana intoxication presenting as seizure. Pediatric Emergency Care. 21: 527-8. PMID 16096599 DOI: 10.1097/01.pec.0000173349.38024.33  1
2005 Sturla LM, Cowan CW, Guenther L, Castellino RC, Kim JY, Pomeroy SL. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death. Cancer Research. 65: 5683-9. PMID 15994942 DOI: 10.1158/0008-5472.CAN-04-2283  1
2005 Fleischman A, Brue C, Poussaint TY, Kieran M, Pomeroy SL, Goumnerova L, Scott RM, Cohen LE. Diencephalic syndrome: a cause of failure to thrive and a model of partial growth hormone resistance. Pediatrics. 115: e742-8. PMID 15930202 DOI: 10.1542/peds.2004-2237  1
2005 Judkins AR, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy SL, Rosenblum MK, Yachnis AT, Zhou H, Rorke LB, Biegel JA. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. Journal of Neuropathology and Experimental Neurology. 64: 391-7. PMID 15892296  1
2005 Zimmerman MA, Goumnerova LC, Proctor M, Scott RM, Marcus K, Pomeroy SL, Turner CD, Chi SN, Chordas C, Kieran MW. Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. Journal of Neuro-Oncology. 72: 77-84. PMID 15803379 DOI: 10.1007/s11060-004-3115-y  1
2005 Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. International Journal of Radiation Oncology, Biology, Physics. 61: 374-9. PMID 15667955 DOI: 10.1016/j.ijrobp.2004.06.012  1
2005 Ullrich NJ, Scott RM, Pomeroy SL. Craniopharyngioma therapy: long-term effects on hypothalamic function. The Neurologist. 11: 55-60. PMID 15631644 DOI: 10.1097/01.nrl.0000149971.27684.d4  1
2004 Goodkin HP, Harper MB, Pomeroy SL. Intracerebral abscess in children: historical trends at Children's Hospital Boston. Pediatrics. 113: 1765-70. PMID 15173504 DOI: 10.1542/peds.113.6.1765  1
2004 Kho AT, Zhao Q, Cai Z, Butte AJ, Kim JY, Pomeroy SL, Rowitch DH, Kohane IS. Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes & Development. 18: 629-40. PMID 15075291 DOI: 10.1101/gad.1182504  1
2004 Fernandez-Teijeiro A, Betensky RA, Sturla LM, Kim JY, Tamayo P, Pomeroy SL. Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 994-8. PMID 14970184 DOI: 10.1200/JCO.2004.03.036  1
2004 Pomeroy S. Dysembryoplastic neuroepithelial tumor (DNT) in childhood Neurology. 62: 2147.  1
2003 Ullrich NJ, Pomeroy SL. Pediatric brain tumors. Neurologic Clinics. 21: 897-913. PMID 14743655 DOI: 10.1016/S0733-8619(03)00014-8  1
2003 Pomeroy SL, Sturla LM. Molecular biology of medulloblastoma therapy. Pediatric Neurosurgery. 39: 299-304. PMID 14734863 DOI: 10.1159/000075257  1
2003 Kim JY, Nelson AL, Algon SA, Graves O, Sturla LM, Goumnerova LC, Rowitch DH, Segal RA, Pomeroy SL. Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice. Developmental Biology. 263: 50-66. PMID 14568546 DOI: 10.1016/S0012-1606(03)00434-2  1
2003 Mink JW, Caruso PA, Pomeroy SL. Progressive myoclonus in a child with a deep cerebellar mass. Neurology. 61: 829-31. PMID 14504331  1
2003 McLaughlin ME, Robson CD, Kieran MW, Jacks T, Pomeroy SL, Cameron S. Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): a case report and laboratory investigation. Journal of Pediatric Hematology/Oncology. 25: 644-8. PMID 12902920 DOI: 10.1097/00043426-200308000-00012  1
2003 Nelson AL, Algon SA, Munasinghe J, Graves O, Goumnerova L, Burstein D, Pomeroy SL, Kim JY. Magnetic resonance imaging of patched heterozygous and xenografted mouse brain tumors. Journal of Neuro-Oncology. 62: 259-67. PMID 12777077 DOI: 10.1023/A:1023339902812  1
2003 Carpentieri SC, Waber DP, Pomeroy SL, Scott RM, Goumnerova LC, Kieran MW, Billett AL, Tarbell NJ. Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurgery. 52: 1348-56; discussion . PMID 12762880  1
2003 Sturla LM, Fernandez-Teijeiro A, Pomeroy SL. Application of microarrays to neurological disease. Archives of Neurology. 60: 676-82. PMID 12756130 DOI: 10.1001/archneur.60.5.676  1
2003 Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Research. 63: 1602-7. PMID 12670911  1
2003 Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. International Journal of Radiation Oncology, Biology, Physics. 55: 1182-5. PMID 12654425 DOI: 10.1016/S0360-3016(02)04391-2  1
2003 Pomeroy SL, Ullrich NJ. Development of the Nervous System Fetal and Neonatal Physiology: Third Edition. 2: 1675-1698. DOI: 10.1016/B978-0-7216-9654-6.50168-5  1
2002 Bhattacharyya A, Watson FL, Pomeroy SL, Zhang YZ, Stiles CD, Segal RA. High-resolution imaging demonstrates dynein-based vesicular transport of activated Trk receptors. Journal of Neurobiology. 51: 302-12. PMID 12150505 DOI: 10.1002/neu.10062  1
2002 Louis DN, Pomeroy SL, Cairncross JG. Focus on central nervous system neoplasia. Cancer Cell. 1: 125-8. PMID 12086870 DOI: 10.1016/S1535-6108(02)00040-5  1
2002 Kim JY, Koralnik IJ, LeFave M, Segal RA, Pfister LA, Pomeroy SL. Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro-Oncology. 4: 165-70. PMID 12084346 DOI: 10.1215/S1522851701000606  1
2002 Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 415: 436-42. PMID 11807556 DOI: 10.1038/415436a  1
2001 Carpentieri SC, Waber DP, Scott RM, Goumnerova LC, Kieran MW, Cohen LE, Kim F, Billett AL, Tarbell NJ, Pomeroy SL. Memory deficits among children with craniopharyngiomas. Neurosurgery. 49: 1053-7; discussion 1. PMID 11846897  1
2001 Dodge PR, Scaer M, Holmes SJ, Pomeroy SL, Feigin RD. Psychometric testing in bacterial meningitis: results of a long-term prospective study of infants and children treated between 1973 and 1977. Journal of Child Neurology. 16: 854-7. PMID 11732773  1
2001 Aguiar RC, Cox G, Pomeroy SL, Dahia PL. Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomas. The Journal of Clinical Endocrinology and Metabolism. 86: 2890-4. PMID 11397905 DOI: 10.1210/jcem.86.6.7547  1
2000 Siffert J, Poussaint TY, Goumnerova LC, Scott RM, LaValley B, Tarbell NJ, Pomeroy SL. Neurological dysfunction associated with postoperative cerebellar mutism. Journal of Neuro-Oncology. 48: 75-81. PMID 11026700 DOI: 10.1023/A:1006483531811  1
2000 Uemura Y, Pak SC, Luke C, Cataltepe S, Tsu C, Schick C, Kamachi Y, Pomeroy SL, Perlmutter DH, Silverman GA. Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells. International Journal of Cancer. Journal International Du Cancer. 89: 368-77. PMID 10956412 DOI: 10.1002/1097-0215(20000720)89:4<368::AID-IJC9>3.0.CO;2-6  1
2000 Pomeroy SL, Kim JY. Biology and pathobiology of neuronal development. Mental Retardation and Developmental Disabilities Research Reviews. 6: 41-6. PMID 10899796 DOI: 10.1002/(SICI)1098-2779(2000)6:1<41::AID-MRDD6>3.0.CO;2-V  1
2000 Dong J, Gailani MR, Pomeroy SL, Reardon D, Bale AE. Identification of PATCHED mutations in medulloblastomas by direct sequencing. Human Mutation. 16: 89-90. PMID 10874314 DOI: 10.1002/1098-1004(200007)16:1<89::AID-HUMU18>3.0.CO;2-7  1
2000 Kim HA, Pomeroy SL, Whoriskey W, Pawlitzky I, Benowitz LI, Sicinski P, Stiles CD, Roberts TM. A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1. Neuron. 26: 405-16. PMID 10839359  1
1999 Watson FL, Heerssen HM, Moheban DB, Lin MZ, Sauvageot CM, Bhattacharyya A, Pomeroy SL, Segal RA. Rapid nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 7889-900. PMID 10479691  1
1999 Liu E, Robertson RL, du Plessis A, Pomeroy SL. Basal ganglia germinoma with progressive cerebral hemiatrophy. Pediatric Neurology. 20: 312-4. PMID 10328283 DOI: 10.1016/S0887-8994(98)00161-1  1
1999 Kim JY, Sutton ME, Lu DJ, Cho TA, Goumnerova LC, Goritchenko L, Kaufman JR, Lam KK, Billet AL, Tarbell NJ, Wu J, Allen JC, Stiles CD, Segal RA, Pomeroy SL. Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Research. 59: 711-9. PMID 9973222  1
1997 Pomeroy SL, Sutton ME, Goumnerova LC, Segal RA. Neurotrophins in cerebellar granule cell development and medulloblastoma. Journal of Neuro-Oncology. 35: 347-52. PMID 9440031 DOI: 10.1023/A:1005841206252  1
1997 Kwon YK, Bhattacharyya A, Alberta JA, Giannobile WV, Cheon K, Stiles CD, Pomeroy SL. Activation of ErbB2 during wallerian degeneration of sciatic nerve. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 8293-9. PMID 9334404  1
1997 Schwartz PM, Borghesani PR, Levy RL, Pomeroy SL, Segal RA. Abnormal cerebellar development and foliation in BDNF-/- mice reveals a role for neurotrophins in CNS patterning. Neuron. 19: 269-81. PMID 9292718 DOI: 10.1016/S0896-6273(00)80938-1  1
1997 Bhattacharyya A, Watson FL, Bradlee TA, Pomeroy SL, Stiles CD, Segal RA. Trk receptors function as rapid retrograde signal carriers in the adult nervous system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 7007-16. PMID 9278536  1
1996 Pomeroy SL, Zurakowski D, Khoxayo S, Endara M, Dikkes P. Postnatal addition of satellite cells to parasympathetic neurons. The Journal of Comparative Neurology. 375: 518-25. PMID 8915846 DOI: 10.1002/(SICI)1096-9861(19961118)375:3<518::AID-CNE12>3.0.CO;2-H  1
1996 Bakardjiev AI, Barnes PD, Goumnerova LC, Black PM, Scott RM, Pomeroy SL, Billett A, Loeffler JS, Tarbell NJ. Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer. 78: 864-73. PMID 8756383 DOI: 10.1002/(SICI)1097-0142(19960815)78:4<864::AID-CNCR25>3.0.CO;2-S  1
1995 Chapman CA, Waber DP, Bernstein JH, Pomeroy SL, LaVally B, Sallan SE, Tarbell N. Neurobehavioral and neurologic outcome in long-term survivors of posterior fossa brain tumors: role of age and perioperative factors. Journal of Child Neurology. 10: 209-12. PMID 7642890  1
1995 Segal RA, Pomeroy SL, Stiles CD. Axonal growth and fasciculation linked to differential expression of BDNF and NT3 receptors in developing cerebellar granule cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 4970-81. PMID 7623126  1
1995 Poussaint TY, Siffert J, Barnes PD, Pomeroy SL, Goumnerova LC, Anthony DC, Sallan SE, Tarbell NJ. Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up. Ajnr. American Journal of Neuroradiology. 16: 693-9. PMID 7611024  1
1994 Dunbar SF, Tarbell NJ, Kooy HM, Alexander E, Black PM, Barnes PD, Goumnerova L, Scott RM, Pomeroy SL, La Vally B. Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. International Journal of Radiation Oncology, Biology, Physics. 30: 531-9. PMID 7928483 DOI: 10.1016/0360-3016(92)90938-E  1
1994 Pomeroy SL. The p53 tumor suppressor gene and pediatric brain tumors. Current Opinion in Pediatrics. 6: 632-5. PMID 7849806  1
1994 Tarbell NJ, Barnes P, Scott RM, Goumnerova L, Pomeroy SL, Black PM, Sallan SE, Billett A, LaVally B, Helmus A. Advances in radiation therapy for craniopharyngiomas. Pediatric Neurosurgery. 21: 101-7. PMID 7841067 DOI: 10.1159/000120870  1
1994 Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proceedings of the National Academy of Sciences of the United States of America. 91: 12867-71. PMID 7809137 DOI: 10.1073/pnas.91.26.12867  1
1992 LaMantia AS, Pomeroy SL, Purves D. Vital imaging of glomeruli in the mouse olfactory bulb. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 976-88. PMID 1545246  1
1992 Pomeroy SL. Brain tumors in children Current Opinion in Pediatrics. 4: 930-934.  1
1990 Pomeroy SL, LaMantia AS, Purves D. Postnatal construction of neural circuitry in the mouse olfactory bulb. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 1952-66. PMID 2355260  1
1990 Pomeroy SL, Holmes SJ, Dodge PR, Feigin RD. Seizures and other neurologic sequelae of bacterial meningitis in children. The New England Journal of Medicine. 323: 1651-7. PMID 2233962 DOI: 10.1056/NEJM199012133232402  1
1990 Pomeroy SL. Neurologic sequelae of bacterial meningitis in children Current Opinion in Pediatrics. 2: 1071-1074.  1
1988 Pomeroy SL, Purves D. Neuron/glia relationships observed over intervals of several months in living mice. The Journal of Cell Biology. 107: 1167-75. PMID 3417780  1
Show low-probability matches.